|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3125888 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713499.0 |
| Date of filing the European patent application | 2015-04-01 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (86) | Number | PCT/EP2015/057224 |
| Date | 2015-04-01 |
| (87) | Number | WO 2015/150476 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 14382130 | 2014-04-02 | EP |
| (72) |
GARC A COLLAZO, Ana Mar a, ES
ECKLAND, David John Augustus, GB
PIZCUETA LALANZA, Maria Pilar, ES
MARTINELL PEDEMONTE, Marc, ES
|
| (73) |
Minoryx Therapeutics S.L.,
Av. Ernest Lluch 32, TCM2, 08302 Matar - Barcelona,
ES
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2,4-Tiazolidindiono dariniai, skirti centrinės nervų sistemos sutrikimų gydymui |
| 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2025-03-17 | 11 | 289.00 EUR |
| 2026-04-01 |